Fsv7
Suite 105, US · Founded 2020 · Delaware corporation
Founders & leadership
MP
Matthew P. PandoNamed on SEC filing
PO
Philip OettingerNamed on SEC filing
KA
K. Angela MacfarlaneNamed on SEC filing
FB
Florian BrandNamed on SEC filing
RB
Ryan BarrettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 1 round · 2020
▶$6.6MraisedNov 2020 · 55 investors · Other Health CareRule 506(b)
▶$6.6MraisedNov 2020 · 55 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew P. PandoExecutive Officer, Director
- Philip OettingerExecutive Officer
- K. Angela MacfarlaneDirector
- Florian BrandDirector
- Ryan BarrettDirector
- Offering amount
- $25.8M
- Amount sold
- $6.6M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fsv7 raised?
- Fsv7 has disclosed $6.6M raised across 1 round.
- Where is Fsv7 headquartered?
- Fsv7 is headquartered in Suite 105, US.